Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin M Hobbs

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Cell|March 10, 2012
Systemic elevation of PTEN induces a tumor-suppressive metabolic stateIsabel Garcia-Cao, Min Sup Song, Robin M Hobbs, et al.
Molecular Cell|October 16, 2020
Control of Glucocorticoid Receptor Levels by PTEN Establishes a Failsafe Mechanism for Tumor SuppressionHon Yan K Yip, Annabel Chee, Ching-Seng Ang, et al.
Cell|April 29, 2014
Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein functionAntonella Papa, Lixin Wan, Massimo Bonora, et al.
Cancer Discovery|February 6, 2015
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and TumorigenesisAndrea Lunardi, Shohreh Varmeh, Ming Chen, et al.
Cancer Discovery|May 29, 2014
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibitionEnrique González-Billalabeitia, Nina Seitzer, Su Jung Song, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Cell|March 10, 2012
Systemic elevation of PTEN induces a tumor-suppressive metabolic stateIsabel Garcia-Cao, Min Sup Song, Robin M Hobbs, et al.
Molecular Cell|October 16, 2020
Control of Glucocorticoid Receptor Levels by PTEN Establishes a Failsafe Mechanism for Tumor SuppressionHon Yan K Yip, Annabel Chee, Ching-Seng Ang, et al.
Cell|April 29, 2014
Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein functionAntonella Papa, Lixin Wan, Massimo Bonora, et al.
Cancer Discovery|February 6, 2015
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and TumorigenesisAndrea Lunardi, Shohreh Varmeh, Ming Chen, et al.
Cancer Discovery|May 29, 2014
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibitionEnrique González-Billalabeitia, Nina Seitzer, Su Jung Song, et al.
Pageof 6